Accueil   Diary - News   All news ADOCIA Reinforces Its Board of Directors with the Appointment of Three New Independent Members

ADOCIA Reinforces Its Board of Directors with the Appointment of Three New Independent Members

 

 

 

ADOCIA (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specialized in the development of innovative formulations of proteins and peptides, announces today the appointment of three independent Directors to the Board of Directors. The appointees: Claudia Mitchell, Katherine Bowdish and Stéphane Boissel joined the board as of May 21, 2021. In parallel, Dominique Takizawa has decided to resign after ten years of service on the board.

 

“We are pleased to welcome three highly talented people at the time where Adocia is progressing in latestage development of key insulin assets while continuing to pioneer new innovative approaches in cell therapy and obesity”, said Gérard Soula, CEO and President of the Board of Directors of Adocia. “On behalf of all board members, I would like to warmly thank Dominique Takizawa for her engagement and expertise.”

 

 

Read the press release